GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Cyclically Adjusted Revenue per Share

Cryo-Cell International (FRA:ZCY) Cyclically Adjusted Revenue per Share : €3.14 (As of Feb. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cryo-Cell International's adjusted revenue per share for the three months ended in Feb. 2024 was €0.882. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.14 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Cryo-Cell International's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cryo-Cell International was 20.40% per year. The lowest was 6.00% per year. And the median was 10.55% per year.

As of today (2024-06-07), Cryo-Cell International's current stock price is €7.45. Cryo-Cell International's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 was €3.14. Cryo-Cell International's Cyclically Adjusted PS Ratio of today is 2.37.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cryo-Cell International was 4.64. The lowest was 0.83. And the median was 2.23.


Cryo-Cell International Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cryo-Cell International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Cyclically Adjusted Revenue per Share Chart

Cryo-Cell International Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.54 3.61

Cryo-Cell International Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 3.27 3.53 3.61 3.14

Competitive Comparison of Cryo-Cell International's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Cryo-Cell International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Cyclically Adjusted PS Ratio falls into.



Cryo-Cell International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cryo-Cell International's adjusted Revenue per Share data for the three months ended in Feb. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=0.882/130.9299*130.9299
=0.882

Current CPI (Feb. 2024) = 130.9299.

Cryo-Cell International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201405 0.342 100.373 0.446
201408 0.362 100.352 0.472
201411 0.389 99.635 0.511
201502 0.424 99.032 0.561
201505 0.447 100.333 0.583
201508 0.501 100.548 0.652
201511 0.578 100.135 0.756
201602 0.518 100.040 0.678
201605 0.543 101.355 0.701
201608 0.745 101.617 0.960
201611 0.799 101.829 1.027
201702 0.729 102.779 0.929
201705 0.730 103.256 0.926
201708 0.749 103.587 0.947
201711 0.724 104.072 0.911
201802 0.710 105.052 0.885
201805 0.697 106.148 0.860
201808 0.814 106.383 1.002
201811 0.970 106.338 1.194
201902 0.784 106.649 0.962
201905 0.863 108.048 1.046
201908 0.875 108.245 1.058
201911 0.863 108.519 1.041
202002 0.860 109.139 1.032
202005 0.890 108.175 1.077
202008 0.838 109.662 1.001
202011 0.783 109.793 0.934
202102 0.692 110.968 0.816
202105 0.717 113.576 0.827
202108 0.734 115.421 0.833
202111 0.729 117.269 0.814
202202 0.731 119.703 0.800
202205 0.844 123.323 0.896
202208 0.902 124.958 0.945
202211 0.895 125.607 0.933
202302 0.866 126.928 0.893
202305 0.858 128.314 0.875
202308 0.865 129.538 0.874
202311 0.878 129.548 0.887
202402 0.882 130.930 0.882

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cryo-Cell International  (FRA:ZCY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cryo-Cell International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.45/3.14
=2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cryo-Cell International was 4.64. The lowest was 0.83. And the median was 2.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cryo-Cell International Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryo-Cell International (FRA:ZCY) Business Description

Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Cryo-Cell International (FRA:ZCY) Headlines

No Headlines